acetylsalicyclic acid (ASA)

DRUG2 trials

Sponsors

Sanofi, Aarhus University Hospital

Conditions

Acute Coronary DiseaseAngina UnstableCovert Brain Infarction

Phase 3

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

CompletedNCT00335452

SanofiAcute Coronary Disease, Angina Unstable

Start: 2006-06-30End: 2009-09-30Updated: 2010-11-18

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

RecruitingNCT07012629

Aarhus University HospitalCovert Brain Infarction

Start: 2025-11-26End: 2040-01-01Target: 1652Updated: 2025-12-04

Related Papers

Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease

Heart2021-01-2741 citations

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Journal of the American Heart Association2017-11-0112 citations

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

2010-10-01512 citations

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

2010-09-01480 citations